The kidney cancer diagnostics market continues on its steady growth trajectory, with revenues in 2018 estimated at over US$ 540 Mn. While demand for a cure-all and precision diagnosis is increasing in the kidney cancer diagnostics market, burden on medical research organizations & hospitals has led the development of novel kidney cancer diagnostics & therapeutic procedures.
Tremendous transformations have been witnessed over the recent past, in the management and diagnosis of renal cell carcinoma (RCC), or, kidney cancer. Numerous discoveries, trails, and studies have been taken in active surveillance, renal biopsy, as well as minimally-invasive thermal ablation, on the back of surging rate of kidney cancer diagnostics, observed usually among individuals with high morbidity risks, undergoing operative treatment.
Older population are most commonly affected by kidney cancer. Diagnosis of old-aged patients makes kidney cancer diagnostics an intricate chapter in the medical books. MRI and CT scan are staple diagnosis procedures in the global market for kidney cancer diagnostics, however, patients are anticipating the emergence of advanced and more effective diagnosis tests.
The urge to upgrade the diagnostic approach for kidney cancer patients is also resonated by medical organizations as they continue to direct heavy investments in research & developments of new diagnostic procedures. Improvements in early diagnosis tests have translated huge profits for market players, and these companies are also partnering with medical research organizations to develop diagnostic methods that can concurrently lower the maturation pace of tumor between multiples stages of kidney cancer.
You can Get Free Sample Report Here @ https://www.factmr.com/connectus/sample?flag=S&rep_id=56
Estimations from Fact.MR’s Report on the Global Kidney Cancer Diagnostics Market
- Based on end-users, the hospital-associated labs will remain preferred in the market for kidney cancer diagnostics, and are expected to account for the largest revenues over the forecast period.
- Independent diagnostic laboratories are estimated to remain the second largest end-users in the for kidney cancer diagnostics market.
- Cancer research institutes will register the fastest expansion in the kidney cancer diagnostics market during the forecast period.
- Immunochemistry tests will remain sought-after in the kidney cancer diagnostics market, and revenues from these tests will account for US$ 351.8 Mn by 2022-end. Among test type, immunochemistry test is expected to exhibit the highest CAGR through 2022, followed by the complete blood count test.
- Urine analysis is anticipated to remain the second most lucrative tests for kidney cancer diagnostics across the globe.
- Revenues from blood chemistry tests related to kidney cancer diagnostics are expected to remain comparatively lower in the market over the forecast period.
- North America will continue to account for the largest revenues in the kidney cancer diagnostics market, followed by Europe.
- Market for kidney cancer diagnostics in Europe will register a relatively higher CAGR than in North America throughout the forecast period.
- Asia Pacific excluding Japan (APEJ) is expected to remain the fastest growing market for kidney cancer diagnostics over the forecast period.
Report Analysis@ https://www.factmr.com/report/56/kidney-cancer-diagnostics-market
Company Profiles
The report has also profiled leading players in the global market for kidney cancer diagnostics, which include NeoGenomics Laboratories, Myriad Genetics Inc, NanoString Technologies Inc., Rosetta Genomics, Sysmex Corporation, Illumina, Inc., Roche Holding AG, Quest Diagnostics Incorporated, Thermo Fisher Scientific Inc., and Abbott Laboratories.
About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Follow us in Linkedin: https://www.linkedin.com/company/factmr/
Your information will never be shared with any third party.